AstraZeneca PLC (AZN)
Company Info
ISIN | US0463531089 |
---|---|
CUSIP | 046353108 |
Sector | Healthcare |
Industry | Drug Manufacturers—General |
Highlights
Market Cap | $201.55B |
---|---|
EPS | $1.89 |
PE Ratio | 33.79 |
PEG Ratio | 0.50 |
Revenue (TTM) | $44.99B |
Gross Profit (TTM) | $35.73B |
EBITDA (TTM) | $18.71B |
Year Range | $61.22 - $76.06 |
Target Price | $82.69 |
Short % | 0.27% |
Short Ratio | 1.11 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of $10,000 in AstraZeneca PLC, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Popular comparisons: AZN vs. MRNA, AZN vs. UNH, AZN vs. VTI, AZN vs. CTLT, AZN vs. VONG, AZN vs. CAH, AZN vs. NVO, AZN vs. NVS, AZN vs. VOO, AZN vs. FSPSX
Return
AstraZeneca PLC had a return of -4.22% year-to-date (YTD) and -5.29% in the last 12 months. Over the past 10 years, AstraZeneca PLC had an annualized return of 12.15%, outperforming the S&P 500 benchmark which had an annualized return of 9.70%.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | -4.22% | 18.49% |
1 month | -0.72% | 4.20% |
6 months | -12.69% | 6.60% |
1 year | -5.29% | 15.43% |
5 years (annualized) | 13.75% | 11.59% |
10 years (annualized) | 12.15% | 9.70% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 | -0.19% | -2.07% | 0.18% | -4.79% | -0.15% | -6.63% | 2.15% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for AstraZeneca PLC (AZN) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
---|---|---|---|---|---|
AZN AstraZeneca PLC | -0.23 | ||||
^GSPC S&P 500 | 1.00 |
Dividend History
AstraZeneca PLC granted a 2.28% dividend yield in the last twelve months. The annual payout for that period amounted to $1.45 per share.
Period | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Dividend | $1.45 | $1.45 | $1.40 | $1.40 | $1.40 | $1.37 | $1.37 | $1.37 | $1.38 | $1.40 | $1.40 | $1.43 |
Dividend yield | 2.28% | 2.14% | 2.40% | 2.80% | 2.81% | 3.61% | 3.95% | 5.01% | 4.06% | 3.98% | 4.72% | 6.03% |
Monthly Dividends
The table displays the monthly dividend distributions for AstraZeneca PLC. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 | $0.00 | $0.99 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.47 | $0.00 | $0.00 | $0.00 | |
2022 | $0.00 | $0.99 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.47 | $0.00 | $0.00 | $0.00 | $0.00 |
2021 | $0.00 | $0.95 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.00 | $0.00 |
2020 | $0.00 | $0.95 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.00 | $0.00 |
2019 | $0.00 | $0.95 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.00 | $0.00 |
2018 | $0.00 | $0.93 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.00 | $0.00 |
2017 | $0.00 | $0.93 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.00 | $0.00 |
2016 | $0.00 | $0.93 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.00 | $0.00 |
2015 | $0.00 | $0.94 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.00 | $0.00 |
2014 | $0.00 | $0.95 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.00 | $0.00 |
2013 | $0.00 | $0.95 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.00 | $0.00 |
2012 | $0.98 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.00 | $0.00 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the AstraZeneca PLC. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the AstraZeneca PLC was 48.94%, occurring on Mar 9, 2009. Recovery took 977 trading sessions.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-48.94% | Oct 26, 2006 | 594 | Mar 9, 2009 | 977 | Jan 24, 2013 | 1571 |
-43.5% | Mar 4, 2002 | 127 | Aug 30, 2002 | 382 | Mar 9, 2004 | 509 |
-34.31% | Apr 7, 1998 | 476 | Feb 24, 2000 | 94 | Jul 10, 2000 | 570 |
-31.26% | Mar 10, 2004 | 221 | Jan 24, 2005 | 229 | Dec 19, 2005 | 450 |
-29.82% | May 2, 2014 | 653 | Dec 1, 2016 | 272 | Jan 2, 2018 | 925 |
Volatility Chart
The current AstraZeneca PLC volatility is 4.68%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.